Heart failure (HF) mortality rates in the Texas panhandle are significantly increased compared with the state average rate, ...

An updated report on statistics regarding heart failure epidemiology and outcomes has been published by the HFSA.

Fatphobia—also known as weight discrimination and bias—can appear in healthcare settings with negative impact on a patient's ...

Topline data were announced from a phase 3 trial evaluating baxdrostat in patients with treatment-resistant hypertension.

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

Guidelines regarding the management of cardiovascular disease in pregnant patients have been published by the European Society of Cardiology.

Topline data were announced from a phase 3 trial evaluating evolocumab in adults at high cardiovascular risk without prior heart attack or stroke.

Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online.

Study findings support intensive blood pressure control in patients with hypertension without chronic kidney disease at baseline.

The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at the annual meeting of the European Association for the Study of Diabetes.

Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study.

Increased hypoxic burden was associated with major cardiovascular and cerebrovascular adverse events (MACCE) in patients with OSA.